Vanguard Portfolio Management »

Protalix Biotherapeutics shares owned by Vanguard Portfolio Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Vanguard Portfolio Management from 13F filings

Historical chart of Vanguard Portfolio Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Vanguard Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $939k 433k 2.17